Numinus Wellness Inc.
Numinus Wellness Inc (NUMI) is a publicly-traded company that is licensed (via Salvation Botanicals) by Health Canada to test, sell and distribute psychedelic substances. It listed on the TSXV exchange on Wednesday 20th May, 2020.
The Company’s operations include Numinus Bioscience, a testing and research facility; Numinus Health, a treatment and healing centre model; and Numinus R&D.
The Company has raised funds via private placements and enjoys revenue from laboratory and production operations in the cannabis sector.
We spoke with Dr. Evan Wood about his plans for Numinus, and his broader opinions on psychedelics and society.
Wood was appointed as Chief Medical Officer of Numinus (TSXV:NUMI) in May 2020. Dr. Wood has an extensive bibliography of published research and has held a suite of positions across a variety of institutions, with a focus on substance use and addiction.
Note: due to the emergent nature of the psychedelics sector, many publicly listed companies do not have complete valuation or financial data.
Join our Newsletter
Get our interviews delivered to your inbox by signing up to our newsletter.